Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB) Coverage Initiated at StockNews.com
StockNews.com initiated coverage on shares of Navidea Biopharmaceuticals (NYSEAMERICAN:NAVB – Get Rating) in a research note released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.09 on Monday. Navidea Biopharmaceuticals has a one year low of $0.07 and a one year […]